Sign In
Buy AUPH
$14.93
+0.360 (+2.47%)
At Close: Aug 04, 2026
Why Aurinia Pharmaceuticals Stock Is Sliding Today
12:22pm, Wednesday, 27'th Jul 2022
An analyst downgraded the stock.
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
09:29am, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Pag
Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022
04:07pm, Monday, 25'th Jul 2022
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that it will release financial and operat
Why Bank Stocks Traded Sharply Higher; Here Are 65 Biggest Movers From Friday
09:43am, Monday, 18'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offer
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
04:11pm, Friday, 15'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Ce
Why Aurinia Pharmaceuticals Stock Is In Retreat Today
04:01pm, Friday, 15'th Jul 2022 The Motley Fool
Investors are none too pleased with the company's recent slew of hires.
Why Aurinia Pharmaceuticals Stock Is In Retreat Today
12:01pm, Friday, 15'th Jul 2022
Investors are none too pleased with the company's recent slew of hires.
Aurinia (AUPH) Moves 13.3% Higher: Will This Strength Last?
07:17am, Tuesday, 05'th Jul 2022 Zacks Investment Research
Aurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Aurinia (AUPH) Moves 13.3% Higher: Will This Strength Last?
04:37am, Tuesday, 05'th Jul 2022
Aurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
A Buyout-Driven Pair Trade: Buy Aurinia, Sell Merck (Or Seagen If You Must)
09:22am, Monday, 04'th Jul 2022
The most recent two hottest potatoes in the biotech arena are Aurinia Pharmaceuticals and Seagen. While the latter is mostly/recently associated with an upcoming Merck buyout, the former has been asso
Why Aurinia Pharmaceuticals Stock Perked Up Today
08:46pm, Friday, 01'st Jul 2022 The Motley Fool
Another buyout rumor is fueling the company's northward move today.
Why Aurinia Pharmaceuticals Stock Perked Up Today
04:46pm, Friday, 01'st Jul 2022
Another buyout rumor is fueling the company's northward move today.
Aurinia: Redemption On Lupkynis Sales And Possible EMA Approval
02:05pm, Friday, 20'th May 2022
Aurinia and its partner OPEL expect a decision from the EMA in the 2nd half of 2022 on whether or not Lupkynis (voclosporin) will be approved for lupus nephritis in the European territories. About $21
PreMarket Prep Stock Of The Day: Good News From Aurinia Pharmaceuticals In A Down Week
06:59pm, Tuesday, 10'th May 2022 Benzinga
Rarely mentioned in the recent chaos in the markets is the biotech sector. With a heavy emphasis in 2020 and 2021 on finding cures and treatments for COVID-19, major drug approvals from the FDA have b
Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q1 2022 Results - Earnings Call Transcript
12:34pm, Tuesday, 10'th May 2022
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Dana Lynch - Director of Corporate Communications & Corporate Affairs Peter Gr
